跳至主要内容
临床试验/TCTR20240618004
TCTR20240618004已完成不适用

THE ROLE OF mRNA EXPRESSION OF THYMIDILATE SYNTHASE (TS), METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR), AND DIHIDROPYRIMIDIN DEHYDROGENASE (DPD) AS PREDICTORS OF NEOADJUVANT CHEMOTHERAPY RESPONSE OF 5FU REGIMEN IN ADVANCED COLORECTAL CANCER

Self funding0 个研究点目标入组 36 人开始时间: 2024年6月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
17 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • The participants in this study were stage III and IV colorectal cancer, with histopathological results of adenocarcinoma obtained by biopsy and were willing to receive adjuvant chemotherapy with Capecitabine + Oxaliplatin.

排除标准

  • We excluded damaged tissue sample, drop-out patients from chemotherapy follow-up, and pathology results of signet ring cell carcinoma and mucinous carcinoma.

研究者

发起方
Self funding

相似试验